GSK248233A is a dual inhibitor targeting Fluc and VEGFR2, exhibiting IC50 values of 1.03 μM and 2 nM, respectively. Additionally, it demonstrates activity against the AGC family and functions as a protein kinase inhibitor for both ATP-dependent and -independent luciferases, potentially impacting Fluc reporter assays [1].